abstract |
The present invention relates to a binding molecule having neutralizing activity against Middle East respiratory syndrome-coronavirus (MERS-CoV). More particularly, the present invention relates to a binding molecule having a superior ability to bind to the S protein of MERS-CoV and also having a neutralizing effect on MERS-CoV and is very useful in preventing, treating, or diagnosing MERS-CoV infection. |